-0.000153017505202456 -0.000214224507283612 -0.000887501530174941 -0.000780389276533221 -0.00131595054474217 -0.000933406781735852 -0.00229526257803893 -0.00229526257803893
Sign Up Today X
Thanks for submitting the form.
Stockreport

HSBC Turns More Bullish on Amgen (AMGN) into 2026 [Yahoo! Finance]

Amgen Inc. (AMGN)  More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
The firm also retained a Buy rating. The call came as part of the firm's 2026 outlook for the pharma sector. HSBC sees the group in a strong position heading into 2026, “even more so if AI panic kicks in.” While its top picks lean toward “growth bucket ideas,” the firm noted that “fallen angels and value could work as well.” On December 11, Amgen Inc. (NASDAQ:AMGN) shared separate news. The U.S. Food and Drug Administration approved UPLIZNA for the treatment of generalized myasthenia gravis, or gMG. The decision gives patients a new targeted option that could offer long-term disease control with just two doses a year, following the initial loading doses. Samantha Masterson, president and chief executive officer of the Myasthenia Gravis Foundation of America, made the following remark: “Managing a rare and chronic illness can mean facing unpredictable relapsing symptoms and demanding treatment schedules. This approval marks an important milestone, offering durable efficacy and a [Read more]
IMPACT SNAPSHOT EVENT TIME: AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMGN alerts
from News Quantified
AMGN
NEWS
AMGN
Earnings
AMGN
Analyst Actions
AMGN
SEC Filings
Stockreport

HSBC Turns More Bullish on Amgen (AMGN) into 2026 [Yahoo! Finance]

Amgen Inc.  (AMGN) 
More Company Research Source: Yahoo! Finance
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
The firm also retained a Buy rating. The call came as part of the firm's 2026 outlook for the pharma sector. HSBC sees the group in a strong position heading into 2026, “even more so if AI panic kicks in.” While its top picks lean toward “growth bucket ideas,” the firm noted that “fallen angels and value could work as well.” On December 11, Amgen Inc. (NASDAQ:AMGN) shared separate news. The U.S. Food and Drug Administration approved UPLIZNA for the treatment of generalized myasthenia gravis, or gMG. The decision gives patients a new targeted option that could offer long-term disease control with just two doses a year, following the initial loading doses. Samantha Masterson, president and chief executive officer of the Myasthenia Gravis Foundation of America, made the following remark: “Managing a rare and chronic illness can mean facing unpredictable relapsing symptoms and demanding treatment schedules. This approval marks an important milestone, offering durable efficacy and a [Read more]
IMPACT SNAPSHOT
EVENT TIME:
AMGN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS